Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-26 @ 1:05 AM
NCT ID: NCT00386334
Description: None
Frequency Threshold: 2
Time Frame: None
Study: NCT00386334
Study Brief: A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Placebo tablets None None 2 None 61 None View
Eszopiclone Eszopiclone 2 mg tablets None None 4 None 86 None View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Appendicitis Perforated SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 10.1 View
Cholecystisis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA 10.1 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 10.1 View
Completed Suicide SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 10.1 View
Stress Urinary Incontinence SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 10.1 View
Rectocele SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 10.1 View
Arteriosclerosis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 10.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MeDRA 10.1 View
Stomach Discomfort SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA10.1 View
Dry Mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA10.1 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA10.1 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA10.1 View
Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA10.1 View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA10.1 View
Influenza SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 10.1 View
Upper Respiratory Tract Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 10.1 View
Back Pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 10.1 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 10.1 View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 10.1 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 10.1 View
Dysgeusia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 10.1 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 10.1 View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 10.1 View
Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 10.1 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 10.1 View
Pharyngolaryngeal Pain SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 10.1 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 10.1 View